Loading...

Quality Assessment History (Last 24 Hours)

313
Total Assessments
313
Completed
0
Processing
0
Failed
Filename Document Type Assessment Tool Status Quality Score Created Time Data Source Actions
archdischild-2023-326124.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 68.8%
11/16 passed
2026-01-10 16:17:16
test.pdf Cohort Study Newcastle-Ottawa Scale (NOS) for Cohort Studies Completed 12.5%
1/8 passed
2026-01-10 16:17:16
A_systematic_review_and_meta-analysis_of_integrated_studies_on_antimicrobial_resistance_in_Vietnam_with_a_focus_on_Enterobacteriaceae_from_a_One_Health_perspective.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 75.0%
12/16 passed
2026-01-10 16:17:16
archdischild-2023-326124.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 75.0%
12/16 passed
2026-01-10 16:17:16
test.pdf Cohort Study Newcastle-Ottawa Scale (NOS) for Cohort Studies Completed 12.5%
1/8 passed
2026-01-10 16:17:16
A_systematic_review_and_meta-analysis_of_integrated_studies_on_antimicrobial_resistance_in_Vietnam_with_a_focus_on_Enterobacteriaceae_from_a_One_Health_perspective.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 75.0%
12/16 passed
2026-01-10 16:17:16
archdischild-2023-326124.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 68.8%
11/16 passed
2026-01-10 16:17:16
test.pdf Cohort Study Newcastle-Ottawa Scale (NOS) for Cohort Studies Completed 12.5%
1/8 passed
2026-01-10 16:17:16
A_systematic_review_and_meta-analysis_of_integrated_studies_on_antimicrobial_resistance_in_Vietnam_with_a_focus_on_Enterobacteriaceae_from_a_One_Health_perspective.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 81.2%
13/16 passed
2026-01-10 16:17:16
archdischild-2023-326124.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 75.0%
12/16 passed
2026-01-10 16:17:16
test.pdf Cohort Study Newcastle-Ottawa Scale (NOS) for Cohort Studies Completed 12.5%
1/8 passed
2026-01-10 16:17:16
A_systematic_review_and_meta-analysis_of_integrated_studies_on_antimicrobial_resistance_in_Vietnam_with_a_focus_on_Enterobacteriaceae_from_a_One_Health_perspective.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 75.0%
12/16 passed
2026-01-10 16:17:16
archdischild-2023-326124.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 75.0%
12/16 passed
2026-01-10 16:17:16
test.pdf Cohort Study Newcastle-Ottawa Scale (NOS) for Cohort Studies Completed 12.5%
1/8 passed
2026-01-10 16:17:16
archdischild-2023-326124.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 68.8%
11/16 passed
2026-01-10 16:17:16
test.pdf Cohort Study Newcastle-Ottawa Scale (NOS) for Cohort Studies Completed 12.5%
1/8 passed
2026-01-10 16:17:16
A_systematic_review_and_meta-analysis_of_integrated_studies_on_antimicrobial_resistance_in_Vietnam_with_a_focus_on_Enterobacteriaceae_from_a_One_Health_perspective.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 81.2%
13/16 passed
2026-01-10 16:17:16
archdischild-2023-326124.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 50.0%
8/16 passed
2026-01-10 16:17:16
test.pdf Cohort Study Newcastle-Ottawa Scale (NOS) for Cohort Studies Completed 25.0%
2/8 passed
2026-01-10 16:17:16
A_systematic_review_and_meta-analysis_of_integrated_studies_on_antimicrobial_resistance_in_Vietnam_with_a_focus_on_Enterobacteriaceae_from_a_One_Health_perspective.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 50.0%
8/16 passed
2026-01-10 16:17:16
A_systematic_review_and_meta-analysis_of_integrated_studies_on_antimicrobial_resistance_in_Vietnam_with_a_focus_on_Enterobacteriaceae_from_a_One_Health_perspective.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 75.0%
12/16 passed
2026-01-10 16:17:16
test.pdf Cohort Study Newcastle-Ottawa Scale (NOS) for Cohort Studies Completed 12.5%
1/8 passed
2026-01-10 16:17:16
joc-26-03-190.pdf Unknown - Completed - 2026-01-10 16:17:16
joc-26-03-190.pdf Other - Completed - 2026-01-10 16:17:16
Evaluation_of_long-term_benefits_and_cost-effectiveness_ofnation-wide_colorectal_cancer_screening_strategies_in_China_in20202060__a_modelling_analysis.pdf Cohort Study Newcastle-Ottawa Scale (NOS) for Cohort Studies Completed 12.5%
1/8 passed
2026-01-10 16:17:16
test.pdf Cohort Study Newcastle-Ottawa Scale (NOS) for Cohort Studies Completed 12.5%
1/8 passed
2026-01-10 16:17:16
A_systematic_review_and_meta-analysis_of_integrated_studies_on_antimicrobial_resistance_in_Vietnam_with_a_focus_on_Enterobacteriaceae_from_a_One_Health_perspective.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 75.0%
12/16 passed
2026-01-10 16:17:16
Camaione_2013_tham_inh_mo_hinh.pdf Unknown - Completed - 2026-01-10 16:17:16
systematic_review_vancomycin_model_pediatric.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 31.2%
5/16 passed
2026-01-10 16:17:16
systematic_review_vancomycin_model_pediatric.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
Li-2021-popPK-Vanco-ARC.pdf Cohort Study Newcastle-Ottawa Scale (NOS) for Cohort Studies Completed 12.5%
1/8 passed
2026-01-10 16:17:16
joc-26-03-190.pdf Cohort Study Newcastle-Ottawa Scale (NOS) for Cohort Studies Completed 0.0%
0/8 passed
2026-01-10 16:17:16
test.pdf Cohort Study Newcastle-Ottawa Scale (NOS) for Cohort Studies Completed 12.5%
1/8 passed
2026-01-10 16:17:16
A_systematic_review_and_meta-analysis_of_integrated_studies_on_antimicrobial_resistance_in_Vietnam_with_a_focus_on_Enterobacteriaceae_from_a_One_Health_perspective.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 75.0%
12/16 passed
2026-01-10 16:17:16
archdischild-2023-326124.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 68.8%
11/16 passed
2026-01-10 16:17:16
sustainability-14-01724-v2.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
peltier-et-al-2007-the-interdependence-of-the-factors-influencing-the-perceived-quality-of-the-online-learning.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
sustainability-13-02752.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
sustainability-14-08138-v2.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
Education_for_sustainable_development_in_higher_education_evaluating_coherence_between_theory_and_praxis.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
sustainability-13-03524-v2.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
sustainability-13-12354-v2_1.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
sustainability-13-12354-v2.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
Chapter_4_-_Building_credibility_from_day_zero_-_Short.pdf Cohort Study Newcastle-Ottawa Scale (NOS) for Cohort Studies Completed 0.0%
0/8 passed
2026-01-10 16:17:16
Widding_et_al._-_2009_-_University-affiliated_Venture_Capital_funds_fundi.pdf Unknown - Completed - 2026-01-10 16:17:16
PRISMA_2020_flow_diagram_new_SRs_v1.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
Cai_2021.pdf Diagnostic Study QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies) Completed 23.1%
3/13 passed
2026-01-10 16:17:16
Fang_2017_1.pdf Diagnostic Study QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies) Completed 15.4%
2/13 passed
2026-01-10 16:17:16
Rampello_2019.pdf Diagnostic Study QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies) Completed 30.8%
4/13 passed
2026-01-10 16:17:16
Rowin_2000.pdf Diagnostic Study QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies) Completed 15.4%
2/13 passed
2026-01-10 16:17:16
Sartucci_2010.pdf Diagnostic Study QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies) Completed 7.7%
1/13 passed
2026-01-10 16:17:16
Srotova_2017.pdf Diagnostic Study QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies) Completed 30.8%
4/13 passed
2026-01-10 16:17:16
Neutrophil_Gelatinase-_Associated_Lipocalin_in_the_Early_Diagnosis_of_Peritonitis-_The_Case_of_Neutrophil_Gelatinase-_Associated_Lipocalin.pdf Diagnostic Study QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies) Completed 0.0%
0/13 passed
2026-01-10 16:17:16
Alvarez_-_2012_-_Effect_of_sprint_interval_training_and_resistance_exercise_on_metabolic_markers_in_overweight_women.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
BadaamZingade_-_2021_-_The_effect_of_traditional_aerobic_exercise_and_sprint_interval_training_on_insulin_resistance_in_men.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Banitalebi_-_2021_-_Sprint_interval_training_vs._combined_aerobic__resistance_training_in_overweight_women_with_type_2.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Cuddy_-_2019_-_Reduced_exertion_high-intensity_interval_training_is_more_effective_at_improving_cardiorespiratory_f.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Freese_-_2015_-_Acute_and_chronic_effects_of_sprint_interval_exercise_on_postprandial_lipemia_in_women_at-risk_for_t.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Gilbertson_-_2019_-_Combining_supervised_run_interval_training_or_moderate-intensity_continuous_training_with_the_diabet.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Honkala_-_2020_-_Exercise_training_improves_adipose_tissue_metabolism_and_vasculature_regardless_of_baseline_glucose.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Jimenez-Maldonado_-_2020_-_Impact_of_high-intensity_interval_training_and_sprint_interval_training_on_peripheral_markers_of_gly.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Motiani_-_2019_-_Effects_of_short-term_sprint_interval_and_moderate-intensity_continuous_training_on_liver_fat_conten.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Ortega_-_2014_-_Higher_insulin-sensitizing_response_after_sprint_interval_compared_to_continuous_exercise.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Petrick_-_2021_-_Endurance_and_sprint_training_improve_glycemia_and_V_O2peak_but_only_frequent_endurance_benefits_blo.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Ruffino_-_2017_-_A_comparison_of_the_health_benefits_of_reduced-exertion_high-intensity_interval_training_REHIT_and.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Sjoros_-_2018_-_Increased_insulin-stimulated_glucose_uptake_in_both_leg_and_arm_muscles_after_sprint_interval_and_mo.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Skleryk_-_2013_-_Two_weeks_of_reduced-volume_sprint_interval_or_traditional_exercise_training_does_not_improve_metabo.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Sun_-_2019_-_Twelve_weeks_of_low_volume_sprint_interval_training_improves_cardio-metabolic_health_outcomes_in_ove.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Alvarez_-_2012_-_Effect_of_sprint_interval_training_and_resistance_exercise_on_metabolic_markers_in_overweight_women.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Alvarez_-_2012_-_Effect_of_sprint_interval_training_and_resistance_exercise_on_metabolic_markers_in_overweight_women.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
BadaamZingade_-_2021_-_The_effect_of_traditional_aerobic_exercise_and_sprint_interval_training_on_insulin_resistance_in_men.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Banitalebi_-_2021_-_Sprint_interval_training_vs._combined_aerobic__resistance_training_in_overweight_women_with_type_2.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 11.8%
2/17 passed
2026-01-10 16:17:16
Cuddy_-_2019_-_Reduced_exertion_high-intensity_interval_training_is_more_effective_at_improving_cardiorespiratory_f.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Freese_-_2015_-_Acute_and_chronic_effects_of_sprint_interval_exercise_on_postprandial_lipemia_in_women_at-risk_for_t.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 11.8%
2/17 passed
2026-01-10 16:17:16
Gilbertson_-_2019_-_Combining_supervised_run_interval_training_or_moderate-intensity_continuous_training_with_the_diabet.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 5.9%
1/17 passed
2026-01-10 16:17:16
Honkala_-_2020_-_Exercise_training_improves_adipose_tissue_metabolism_and_vasculature_regardless_of_baseline_glucose.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 5.9%
1/17 passed
2026-01-10 16:17:16
Jimenez-Maldonado_-_2020_-_Impact_of_high-intensity_interval_training_and_sprint_interval_training_on_peripheral_markers_of_gly.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Motiani_-_2019_-_Effects_of_short-term_sprint_interval_and_moderate-intensity_continuous_training_on_liver_fat_conten.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Ortega_-_2014_-_Higher_insulin-sensitizing_response_after_sprint_interval_compared_to_continuous_exercise.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 5.9%
1/17 passed
2026-01-10 16:17:16
Petrick_-_2021_-_Endurance_and_sprint_training_improve_glycemia_and_V_O2peak_but_only_frequent_endurance_benefits_blo.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 5.9%
1/17 passed
2026-01-10 16:17:16
Skleryk_-_2013_-_Two_weeks_of_reduced-volume_sprint_interval_or_traditional_exercise_training_does_not_improve_metabo.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 5.9%
1/17 passed
2026-01-10 16:17:16
Ruffino_-_2017_-_A_comparison_of_the_health_benefits_of_reduced-exertion_high-intensity_interval_training_REHIT_and.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 11.8%
2/17 passed
2026-01-10 16:17:16
Sjoros_-_2018_-_Increased_insulin-stimulated_glucose_uptake_in_both_leg_and_arm_muscles_after_sprint_interval_and_mo.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 23.5%
4/17 passed
2026-01-10 16:17:16
Sun_-_2019_-_Twelve_weeks_of_low_volume_sprint_interval_training_improves_cardio-metabolic_health_outcomes_in_ove.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 5.9%
1/17 passed
2026-01-10 16:17:16
Alvarez_-_2012_-_Effect_of_sprint_interval_training_and_resistance_exercise_on_metabolic_markers_in_overweight_women.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 5.9%
1/17 passed
2026-01-10 16:17:16
BadaamZingade_-_2021_-_The_effect_of_traditional_aerobic_exercise_and_sprint_interval_training_on_insulin_resistance_in_men.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 17.6%
3/17 passed
2026-01-10 16:17:16
Banitalebi_-_2021_-_Sprint_interval_training_vs._combined_aerobic__resistance_training_in_overweight_women_with_type_2.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 23.5%
4/17 passed
2026-01-10 16:17:16
Cuddy_-_2019_-_Reduced_exertion_high-intensity_interval_training_is_more_effective_at_improving_cardiorespiratory_f.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 5.9%
1/17 passed
2026-01-10 16:17:16
Freese_-_2015_-_Acute_and_chronic_effects_of_sprint_interval_exercise_on_postprandial_lipemia_in_women_at-risk_for_t.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 17.6%
3/17 passed
2026-01-10 16:17:16
Gilbertson_-_2019_-_Combining_supervised_run_interval_training_or_moderate-intensity_continuous_training_with_the_diabet.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 11.8%
2/17 passed
2026-01-10 16:17:16
Honkala_-_2020_-_Exercise_training_improves_adipose_tissue_metabolism_and_vasculature_regardless_of_baseline_glucose.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Jimenez-Maldonado_-_2020_-_Impact_of_high-intensity_interval_training_and_sprint_interval_training_on_peripheral_markers_of_gly.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Motiani_-_2019_-_Effects_of_short-term_sprint_interval_and_moderate-intensity_continuous_training_on_liver_fat_conten.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Ortega_-_2014_-_Higher_insulin-sensitizing_response_after_sprint_interval_compared_to_continuous_exercise.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 5.9%
1/17 passed
2026-01-10 16:17:16
Petrick_-_2021_-_Endurance_and_sprint_training_improve_glycemia_and_V_O2peak_but_only_frequent_endurance_benefits_blo.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Ruffino_-_2017_-_A_comparison_of_the_health_benefits_of_reduced-exertion_high-intensity_interval_training_REHIT_and.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Sjoros_-_2018_-_Increased_insulin-stimulated_glucose_uptake_in_both_leg_and_arm_muscles_after_sprint_interval_and_mo.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 17.6%
3/17 passed
2026-01-10 16:17:16
Skleryk_-_2013_-_Two_weeks_of_reduced-volume_sprint_interval_or_traditional_exercise_training_does_not_improve_metabo.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 5.9%
1/17 passed
2026-01-10 16:17:16
Sun_-_2019_-_Twelve_weeks_of_low_volume_sprint_interval_training_improves_cardio-metabolic_health_outcomes_in_ove.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 11.8%
2/17 passed
2026-01-10 16:17:16
Alvarez_-_2012_-_Effect_of_sprint_interval_training_and_resistance_exercise_on_metabolic_markers_in_overweight_women.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
BadaamZingade_-_2021_-_The_effect_of_traditional_aerobic_exercise_and_sprint_interval_training_on_insulin_resistance_in_men.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Banitalebi_-_2021_-_Sprint_interval_training_vs._combined_aerobic__resistance_training_in_overweight_women_with_type_2.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Cuddy_-_2019_-_Reduced_exertion_high-intensity_interval_training_is_more_effective_at_improving_cardiorespiratory_f.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Freese_-_2015_-_Acute_and_chronic_effects_of_sprint_interval_exercise_on_postprandial_lipemia_in_women_at-risk_for_t.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Gilbertson_-_2019_-_Combining_supervised_run_interval_training_or_moderate-intensity_continuous_training_with_the_diabet.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Honkala_-_2020_-_Exercise_training_improves_adipose_tissue_metabolism_and_vasculature_regardless_of_baseline_glucose.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Jimenez-Maldonado_-_2020_-_Impact_of_high-intensity_interval_training_and_sprint_interval_training_on_peripheral_markers_of_gly.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Motiani_-_2019_-_Effects_of_short-term_sprint_interval_and_moderate-intensity_continuous_training_on_liver_fat_conten.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Ortega_-_2014_-_Higher_insulin-sensitizing_response_after_sprint_interval_compared_to_continuous_exercise.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Petrick_-_2021_-_Endurance_and_sprint_training_improve_glycemia_and_V_O2peak_but_only_frequent_endurance_benefits_blo.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Ruffino_-_2017_-_A_comparison_of_the_health_benefits_of_reduced-exertion_high-intensity_interval_training_REHIT_and.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Sjoros_-_2018_-_Increased_insulin-stimulated_glucose_uptake_in_both_leg_and_arm_muscles_after_sprint_interval_and_mo.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Skleryk_-_2013_-_Two_weeks_of_reduced-volume_sprint_interval_or_traditional_exercise_training_does_not_improve_metabo.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Sun_-_2019_-_Twelve_weeks_of_low_volume_sprint_interval_training_improves_cardio-metabolic_health_outcomes_in_ove.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
elife-04490-v2.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
Berinstein_1998.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 100.0%
17/17 passed
2026-01-10 16:17:16
Ipek_2021.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 88.2%
15/17 passed
2026-01-10 16:17:16
Saedi_2016.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 94.1%
16/17 passed
2026-01-10 16:17:16
Vural_2023.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 100.0%
17/17 passed
2026-01-10 16:17:16
Vural_2025.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 100.0%
17/17 passed
2026-01-10 16:17:16
JSURGRES-D-25-01704_1.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
NEJMoa1503093.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
World_j_surg_-_2004_-_Wang_-_Molecular_Detection_of_APC_Kras_and_p53_Mutations_in_the_Serum_of_Colorectal_Cancer.pdf Cohort Study Newcastle-Ottawa Scale (NOS) for Cohort Studies Completed 0.0%
0/8 passed
2026-01-10 16:17:16
carroll_2024_oi_231495_1704490532.6214.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
The_impact_of_using_pictorial_aids_in_caregivers__3.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Yin_et_al._-_2021_-_Preventing_Home_Medication_Administration_Errors.pdf Unknown - Completed - 2026-01-10 16:17:16
j_acap_2010_12_007_--_7ccfa682a71ef7b8dd9a46bb8f21954c_--_Annas_Archive_1.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
EBSCO-FullText-08_26_2025_2.pdf Unknown - Completed - 2026-01-10 16:17:16
Journal_of_Advanced_Nursing_-_2014_-_He_-_A_randomized_controlled_trial_of_the_effectiveness_of_an_educational_intervention.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
The_impact_of_using_pictorial_aids_in_caregivers__3.pdf Case-Control Study Newcastle-Ottawa Scale (NOS) for Case-Control Studies Completed 0.0%
0/8 passed
2026-01-10 16:17:16
Yin_et_al._-_2021_-_Preventing_Home_Medication_Administration_Errors.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
s13287-025-04377-4.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
pubmed.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
bhan.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
scrt446.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
AICARE.pdf Unknown - Completed - 2026-01-10 16:17:16
artikel_1.pdf Cross-sectional Study AXIS Tool for Cross-sectional Studies Completed 0.0%
0/10 passed
2026-01-10 16:17:16
artikel_2.pdf Diagnostic Study QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies) Completed 0.0%
0/13 passed
2026-01-10 16:17:16
artikel_3.pdf Unknown - Completed - 2026-01-10 16:17:16
artikel_1.pdf Cross-sectional Study AXIS Tool for Cross-sectional Studies Completed 0.0%
0/10 passed
2026-01-10 16:17:16
Kang-2024.pdf Cohort Study Newcastle-Ottawa Scale (NOS) for Cohort Studies Completed 0.0%
0/8 passed
2026-01-10 16:17:16
Kang-2023-Management-of-asymptomatic-to-mild-.pdf Cohort Study Newcastle-Ottawa Scale (NOS) for Cohort Studies Completed 0.0%
0/8 passed
2026-01-10 16:17:16
Kang-2021.pdf Unknown - Completed - 2026-01-10 16:17:16
2021.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
2019.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
2021.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Liu2018.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Ye2024.pdf Unknown - Completed - 2026-01-10 16:17:16
Ye2024.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Characterizing-healthcare-resource-utilization-in-two-rare-diseases-Kleefstra-syndrome-and-SLC6A1-epileptic-encephalopathy-using-multimodal-realworld-dataOrphanet-Journal-of-Rare-Diseases.pdf Cohort Study Newcastle-Ottawa Scale (NOS) for Cohort Studies Completed 0.0%
0/8 passed
2026-01-10 16:17:16
5.jccnc-v9n3p215-en.pdf Cross-sectional Study AXIS Tool for Cross-sectional Studies Completed 0.0%
0/10 passed
2026-01-10 16:17:16
The-enjoyment-of-life-in-patients-with-Alzheimers-disease-correlations-with-caregivers-perceptions-caregiving-attitudes-and-empowerment-levelsBMC-Nursing.pdf Cross-sectional Study AXIS Tool for Cross-sectional Studies Completed 0.0%
0/10 passed
2026-01-10 16:17:16
s41598-024-81658-7.pdf Cohort Study Newcastle-Ottawa Scale (NOS) for Cohort Studies Completed 0.0%
0/8 passed
2026-01-10 16:17:16
Hochfeld_2016.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Calmarza_-_Relationship_between_lipoproteina.pdf Cohort Study Newcastle-Ottawa Scale (NOS) for Cohort Studies Completed 0.0%
0/8 passed
2026-01-10 16:17:16
Cao_-_Lipoproteina_levels_are_associated_with_subclinical_calcific.pdf Cohort Study Newcastle-Ottawa Scale (NOS) for Cohort Studies Completed 0.0%
0/8 passed
2026-01-10 16:17:16
Cassldy_-_Sex-specifi_c_associations_of_lipoproteina_with.pdf Cohort Study Newcastle-Ottawa Scale (NOS) for Cohort Studies Completed 0.0%
0/8 passed
2026-01-10 16:17:16
Chehab_-_Association_of_Lipoproteina_Levels_With_Myocardial_Fibrosis_in.pdf Cohort Study Newcastle-Ottawa Scale (NOS) for Cohort Studies Completed 0.0%
0/8 passed
2026-01-10 16:17:16
Cho_-_Increased_risk_of_coronary_artery_calcification_progression_in_subjects_with.pdf Cohort Study Newcastle-Ottawa Scale (NOS) for Cohort Studies Completed 0.0%
0/8 passed
2026-01-10 16:17:16
Chung_-_Coronary_calcification_is_associated_with_elevated.pdf Cohort Study Newcastle-Ottawa Scale (NOS) for Cohort Studies Completed 0.0%
0/8 passed
2026-01-10 16:17:16
Jang_M_-_Differential_impact_of_lipoproteina.pdf Cohort Study Newcastle-Ottawa Scale (NOS) for Cohort Studies Completed 0.0%
0/8 passed
2026-01-10 16:17:16
annane2002.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
000.abusive_-_Copy.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
0.tepper2000.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
1-s2.0-S014829632200056X-main.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
1-s2.0-S097038962300099X-main.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
1-s2.0-S0148296324006453-main.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
1-s2.0-S0261517723000018-main.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
1-s2.0-S1029313223000775-main.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
4.Coping_With_Perceived_Abusive_Supervision_The_Role_of_Paranoia.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
6.Abusive_according_to_whom_Manager_and_subordinate_perceptions_of_abusive_supervision_and_supervisors_performance.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
7.A_cross-cultural_examination_of_subordinates_perceptions_of_and_reactions_to_abusive_supervision.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
16.The_Consequences_of_Incongruent_Abusive_Supervision_Anticipation_of_Social_Exclusion_Shame_and_Turnover_Intentions.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
18.MY_FAMILY_MADE_ME_DO_IT_A_CROSS-DOMAIN_SELF-REGULATORY_PERSPECTIVE_ON_ANTECEDENTS_TO_ABUSIVE_SUPERVISION.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
27.How_to_Cope_with_an_Abusive_Leader_Examinations_of_Subordinates_Affective_Reactions_CWB-O_and_Turnover_Intentions.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
29.Making_nice_or_faking_nice_Exploring_supervisors_two-faced_response_to_their_past_abusive_behavior.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
32.Good_Bad_and_Ugly_Leadership_Patterns_Implications_for_Followers_Work-Related_and_Context-Free_Outcomes.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
37.The_dark_side_of_leadership_a_systematic_literature_review.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
1452-48642402393B.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
3104-9765-1-PB.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
a0030687.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
a0038513.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
Abusive_leadership_and_employee_commitment_nexus_Conservation_of_resources_theory_perspective.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
admsci-12-00054-v2.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
admsci-13-00096.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
admsci-14-00177.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
admsci-14-00340.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
admsci-15-00171.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
amj.2015.0460.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
annurev-orgpsych-041015-062539-_NO_NEED_TO_ADD.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
arshad-et-al-2025-impact-of-abusive-supervision-on-employee-engagement-and-job-burnout-via-organisational.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
bjm-09-2021-0338.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
chan-et-al-2023-the-intuitive-and-counterintuitive-effects-of-supportive-and-abusive-supervision-on-hotel-employees.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
de-clercq-et-al-2021-abusive-supervision-occupational-well-being-and-job-performance-the-critical-role-of-attention.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
document.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
Employee_creativity_deterrence.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
1_Systematic_Review_of_Shift_Work_and_Nurses_Health.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
2_Night_shift_work_and_female_breast_cancer_A_Two-Stage_Dose-Response_Meta-Analysis_for_the_Correct_Risk_Definition.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
10549_2022_Article_6792.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
10549_2022_Article_6792.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
10549_2022_Article_6792.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
10549_2022_Article_6792.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
10549_2022_Article_6792.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
12._peerj-18198.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
9._Zamparini_2024.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
123.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
j.1540-8183.2011.00666.x.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
j.1540-8183.2011.00666.x.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
paper_41.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
paper_41.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
paper_321.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
paper_41.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
PHISICAL_ABUSE.pdf Cross-sectional Study AXIS Tool for Cross-sectional Studies Completed 0.0%
0/10 passed
2026-01-10 16:17:16
ILLUMINATING.pdf Cohort Study Newcastle-Ottawa Scale (NOS) for Cohort Studies Completed 0.0%
0/8 passed
2026-01-10 16:17:16
88_Aalbers_2015.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
146_Alabas_2023.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Tessitore_et_al-2015-Headache-_The_Journal_of_Head_and_Face_Pain.pdf Other - Completed - 2026-01-10 16:17:16
Tessitore_et_al-2015-Headache-_The_Journal_of_Head_and_Face_Pain.pdf Cohort Study Newcastle-Ottawa Scale (NOS) for Cohort Studies Completed 0.0%
0/8 passed
2026-01-10 16:17:16
chronic_pain_patients_are_impaired_on_an_emotional.17.pdf Cohort Study Newcastle-Ottawa Scale (NOS) for Cohort Studies Completed 0.0%
0/8 passed
2026-01-10 16:17:16
Arthritis_Care_Research_-_2002_-_Dick_-_Attentional_functioning_in_fibromyalgia_rheumatoid_arthritis_and.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Longterm_smallfiber_neuropathy_and_pain_sensitization.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Long-term_alterations_in_somatosensory_functioning_in_survivors_of_childhood_cancer.pdf Cohort Study Newcastle-Ottawa Scale (NOS) for Cohort Studies Completed 0.0%
0/8 passed
2026-01-10 16:17:16
Long-term_alterations_in_somatosensory_functioning_in_survivors_of_childhood_cancer.pdf Case-Control Study Newcastle-Ottawa Scale (NOS) for Case-Control Studies Completed 0.0%
0/8 passed
2026-01-10 16:17:16
Alam_et_al._-_2025_-_Co-Pilot_for_Project_Managers_Developing_a_PDF-Driven_AI_Chatbot_for_Facilitating_Project_Managemen.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
Teguh_et_al._-_2024_-_Optimizing_IT_Governance_and_Project_Management_in_Software_Development_through_AI_Integration_and_C.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
Siddiqa_et_al._-_2024_-_AI-Driven_Project_Management_Systems_Enhancing_IT_Project_Efficiency_Through_MIS_Integration.pdf Unknown - Completed - 2026-01-10 16:17:16
Saxena_and_Totaro_-_2024_-_Artificial_Intelligence_in_Project_Management_Impacts_on_Efficiency_Innovation__Competitive_Edge.pdf Cross-sectional Study AXIS Tool for Cross-sectional Studies Completed 0.0%
0/10 passed
2026-01-10 16:17:16
Pospieszny_et_al._-_2017_-_An_effective_approach_for_software_project_effort_and_duration_estimation_with_machine_learning_algo.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Permana_et_al._-_2024_-_Large_Language_Model_Employment_for_Story_Point_Estimation_Problems_in_AGILE_Development.pdf Unknown - Completed - 2026-01-10 16:17:16
Nabot_et_al._-_2025_-_AI_for_Software_Project_Management_Predicting_Delivery_Times__Resource_Allocation.pdf Unknown - Completed - 2026-01-10 16:17:16
Mood_-_2025_-_Practical_AI_in_Agile_Project_Management_Reducing_Friction_in_Distributed_Teams.pdf Unknown - Completed - 2026-01-10 16:17:16
Marchinares_and_Rodriguez_-_2021_-_Online_Solution_Based_on_Machine_Learning_for_IT_Project_Management_in_Software_Factory_Companies.pdf Unknown - Completed - 2026-01-10 16:17:16
Lano_et_al._-_2021_-_Automated_Requirements_Formalisation_for_Agile_MDE.pdf Unknown - Completed - 2026-01-10 16:17:16
Kumar_et_al._-_2022_-_User_Story_Splitting_in_Agile_Software_Development_using_Machine_Learning_Approach.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
Kasture_et_al._-_2025_-_Artificial_Intelligence-Driven_Cloud-Native_Big_Data_Analytics_for_Agile_Decision-Making_in_Dynamic.pdf Cross-sectional Study AXIS Tool for Cross-sectional Studies Completed 0.0%
0/10 passed
2026-01-10 16:17:16
Hany_et_al._-_2025_-_A_Two-Phase_NLP-Driven_Deep_Learning_Framework_for_Automated_Software_Requirements_Classification_an.pdf Unknown - Completed - 2026-01-10 16:17:16
Goyal_and_Gupta_-_2025_-_Incorporating_Machine_Learning_into_Agile_Scrum_for_Predictive_Defect_Management.pdf Diagnostic Study QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies) Completed 0.0%
0/13 passed
2026-01-10 16:17:16
Gamage_et_al._-_2024_-_Estimating_Story_Points_in_Scrum_Balancing_Accuracy_and_Interpretability_with_Explainable_AI.pdf Unknown - Completed - 2026-01-10 16:17:16
Revista_FAIMA_Vol13_Issue1_March2025.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
AI-Driven_Project_Management_Sees_90_Positive_ROI_Among_Users.pdf Unknown - Completed - 2026-01-10 16:17:16
Bisaria_et_al._-_2025_-_Explainable_AI-Based_Decision_Support_System_for_Real-Time_Project_Management_Optimization.pdf Unknown - Completed - 2026-01-10 16:17:16
Blazevics_et_al._-_2025_-_A_Framework_for_Model-Driven_AI-Assisted_Generation_of_IT_Project_Management_Plan_and_Scope_Document.pdf Unknown - Completed - 2026-01-10 16:17:16
Shafiq_et_al._-_2021_-_TaskAllocator_A_Recommendation_Approach_for_Role-based_Tasks_Allocation_in_Agile_Software_Developme.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
Arachchi_and_Amalraj_-_2023_-_An_Agile_Project_Management_Supporting_Approach_for_Estimating_Story_Points_in_User_Stories.pdf Unknown - Completed - 2026-01-10 16:17:16
Brown_R..pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Brown.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Daly.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Dawson.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Dean.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
DINESE1.PDF Qualitative Study - Completed - 2026-01-10 16:17:16
Ekegren.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Eriksson_Lindstrom_Ekenberg_-_2011_-_Patients_experiences_of_telerehabilitation_at_home_after_shoulder_joint_replacement.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Flores-Sandoval.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Gaboury.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Hudon.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
JANSEN1.PDF Qualitative Study - Completed - 2026-01-10 16:17:16
JOHNSS1.PDF Qualitative Study - Completed - 2026-01-10 16:17:16
Kringle.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Kwok.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Lee.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
OShea.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Ouedraogo.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
OWNSWO1.PDF Qualitative Study - Completed - 2026-01-10 16:17:16
Philip.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Thomas_et_al._-_2018_-_Parent_experiences_of_variations_in_service_delivery_of_Rapid_Syllable_Transition_ReST_treatment_for_childhood.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Wiley.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Aarabi_et_al..pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Aliaga-Castillo.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Angell_A._M.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Barboza.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Bourke.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Brown_R..pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Brown.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Daly.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Dawson.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Dean.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
DINESE1.PDF Qualitative Study - Completed - 2026-01-10 16:17:16
Ekegren.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Eriksson_Lindstrom_Ekenberg_-_2011_-_Patients_experiences_of_telerehabilitation_at_home_after_shoulder_joint_replacement.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Flores-Sandoval.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Gaboury.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Hudon.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
JANSEN1.PDF Qualitative Study - Completed - 2026-01-10 16:17:16
JOHNSS1.PDF Qualitative Study - Completed - 2026-01-10 16:17:16
Kringle.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Kwok.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Lee.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
OShea.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Ouedraogo.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
OWNSWO1.PDF Qualitative Study - Completed - 2026-01-10 16:17:16
Philip.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Thomas_et_al._-_2018_-_Parent_experiences_of_variations_in_service_delivery_of_Rapid_Syllable_Transition_ReST_treatment_for_childhood.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Wiley.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Aarabi_et_al..pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Aliaga-Castillo.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Angell_A._M.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Barboza.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Bourke.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Angell_A._M.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
Brown.pdf Qualitative Study - Completed - 2026-01-10 16:17:16
pettersson_1989.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
41598_2024_Article_81207.pdf Case-Control Study Newcastle-Ottawa Scale (NOS) for Case-Control Studies Completed 0.0%
0/8 passed
2026-01-10 16:17:16
EDJ_Volume_70_Issue_1_Pages_461-471.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
J_Esthet_Restor_Dent_-_2023_-_Ashraf_-_Effect_of_different_intraoral_scanners_and_scanbody_splinting_on_accuracy_of.pdf Cohort Study Newcastle-Ottawa Scale (NOS) for Cohort Studies Completed 0.0%
0/8 passed
2026-01-10 16:17:16
1.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
2.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
Accuracy_of_Complete_Arch_Implant_Digita.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
Clinical_Oral_Implants_Res_-_2024_-_Cheng_-_Accuracy_of_edentulous_fullarch_implant_impression_An_in_vitro_comparison.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
clinical.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
JIPS-25-3.pdf Systematic Review AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) Completed 0.0%
0/16 passed
2026-01-10 16:17:16
1.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
tsung-et-al-2025-multicenter-phase-ii-study-of-olaparib-and-the-atr-inhibitor-ceralasertib-in-metastatic-castration.pdf RCT Cochrane RoB 2 (Risk of Bias tool for randomized trials) Completed 0.0%
0/17 passed
2026-01-10 16:17:16
1._Glehen_Multi-institutional.pdf Cohort Study Newcastle-Ottawa Scale (NOS) for Cohort Studies Completed 0.0%
0/8 passed
2026-01-10 16:17:16
Usage Instructions
  • History Records: Shows all quality assessments from the last 24 hours
  • View: View detailed assessment results and quality analysis reports
  • Refresh: Manually check processing status (only shown for processing items)
  • Package: Download complete assessment package with data file (Excel/CSV) + beautiful PDF report (only shown for completed assessments)
  • Quality Scores: Calculated based on passed criteria - Green(≥80%), Blue(70-79%), Yellow(60-69%), Red(<60%)
  • Auto-refresh: Processing assessments auto-update status, data retained for 24 hours then auto-cleaned